Trials / Completed
CompletedNCT03767361
Study the Effect of Blood Transfusion on Oxidant-antioxidant Status in Term and Near-term Neonates
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Rania Ali El-Farrash · Academic / Other
- Sex
- All
- Age
- 35 Weeks – 37 Weeks
- Healthy volunteers
- Not accepted
Summary
Primary aim is to evaluate the effect of blood transfusion on oxidant-antioxidant status in premature neonates. Secondary aim is to assess the effect of the age of transfused red blood cells on the biological markers of oxidative stress.
Detailed description
Oxidant-antioxidant status will be assessed by measuring total antioxidant capacity (TAC) and malondialdehyde (MDA), as well as antioxidant minerals, in 65 term and near-term neonates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | packed red blood cells transfusion | packed red blood cells transfusion |
Timeline
- Start date
- 2018-06-13
- Primary completion
- 2019-11-01
- Completion
- 2020-02-26
- First posted
- 2018-12-06
- Last updated
- 2020-09-02
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03767361. Inclusion in this directory is not an endorsement.